Anders H. Forslund

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Effect of dietary counseling and dietary fiber on tolerability during weight management with EMP16 and conventional orlistat: a single-blind randomized pilot trial.

Effect of dietary counseling and dietary fiber on tolerability during weight management with EMP16 and conventional orlistat: a single-blind randomized pilot trial.

Journal: Scientific reports

Published: March 27, 2026

Correction: Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS.

Correction: Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS.

Journal: Cardiovascular diabetology

Published: November 02, 2025

The GLP-1 Agonist Exenatide Is Associated with Improved Adherence to Health Behavior and Lifestyle Treatment in Adolescents with Obesity: A Randomized Controlled Trial.

The GLP-1 Agonist Exenatide Is Associated with Improved Adherence to Health Behavior and Lifestyle Treatment in Adolescents with Obesity: A Randomized Controlled Trial.

Journal: Obesity facts

Published: October 29, 2025

Combining GLP-1 Receptor Agonists and Health-Behaviour and Lifestyle Therapy Yields Higher Adherence and Reduces Session Needs for Successful Weight Management in Adolescence: An Observational Real-World Single-Center Study.

Combining GLP-1 Receptor Agonists and Health-Behaviour and Lifestyle Therapy Yields Higher Adherence and Reduces Session Needs for Successful Weight Management in Adolescence: An Observational Real-World Single-Center Study.

Journal: Pediatric obesity

Published: September 19, 2025

Evaluation of BMI Growth Charts for Children Living with Severe Obesity.

Evaluation of BMI Growth Charts for Children Living with Severe Obesity.

Journal: Childhood obesity (Print)

Published: June 26, 2025

Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS.

Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS.

Journal: Cardiovascular diabetology

Published: April 14, 2025

The Supportive Effect of Acarbose to Orlistat in Weight Management-A Randomized, Double-Blind, Multiarm Phase 2 Trial.

The Supportive Effect of Acarbose to Orlistat in Weight Management-A Randomized, Double-Blind, Multiarm Phase 2 Trial.

Journal: Obesity (Silver Spring, Md.)

Published: April 08, 2025

A Comparative Analysis of the Pharmacodynamic and Pharmacokinetic Properties of 2 Controlled-Release Formulations Versus a Marketed Orlistat Product.

A Comparative Analysis of the Pharmacodynamic and Pharmacokinetic Properties of 2 Controlled-Release Formulations Versus a Marketed Orlistat Product.

Journal: Clinical pharmacology in drug development

Published: October 29, 2024

Validation of Fat Mass Metrics in Pediatric Obesity.

Validation of Fat Mass Metrics in Pediatric Obesity.

Journal: Annals of nutrition & metabolism

Published: July 04, 2024

Rise in fasting and dynamic glucagon levels in children and adolescents with obesity is moderate in subjects with impaired fasting glucose but accentuated in subjects with impaired glucose tolerance or type 2 diabetes.

Rise in fasting and dynamic glucagon levels in children and adolescents with obesity is moderate in subjects with impaired fasting glucose but accentuated in subjects with impaired glucose tolerance or type 2 diabetes.

Journal: Frontiers in endocrinology

Published: January 10, 2024

Maternal body mass index, gestational weight gain, and early childhood growth: A register-based cohort study.

Maternal body mass index, gestational weight gain, and early childhood growth: A register-based cohort study.

Journal: Acta obstetricia et gynecologica Scandinavica

Published: December 14, 2023

Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control.

Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control.

Journal: Frontiers in endocrinology

Published: September 12, 2023

Showing 1-12 of 62

Last Updated: 09/26/2026